 MIAMI, June 22, 2021 PRNewswire -- BioReference Laboratories, Inc., an OPKO Health company NASDAQ: OPK, today announced a COVID-19 testing program for U.S. based crew and guests who cruise with Royal Caribbean Group, helping provide a safe environment for travelers. BioReference announced a COVID-19 testing program for U.S. based crew and guests who cruise with Royal Caribbean Group. 